Results
Latest quarterly results
Companies that reported quarterly results recently, newest first. Each row compares the reported quarter with the same quarter a year earlier. Figures in USD; revenue and net income in millions.
SectorAll 3892Healthcare 878Financial Services 629Technology 560Industrials 517Consumer Cyclical 330Basic Materials 232Energy 196Communication Services 168Real Estate 161Consumer Defensive 134Utilities 87
| Company | Sector | Reported | Quarter | Revenue | Rev. YoY | Net income | NI YoY | EPS | EPS YoY | Op. margin | Margin chg. | Market cap |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SPRYARS Pharmaceuticals, Inc. | Healthcare | Nov 5 | Sep '26 | $38.0M | +15.2% | −$36.0M | n/m | −$0.36 | n/m | -90.6% | +73.0 pp | $367M |
| CCCCC4 Therapeutics, Inc. | Healthcare | Nov 5 | Sep '26 | $8.0M | −27.3% | −$22.0M | n/m | −$0.16 | n/m | -290.5% | +16.0 pp | $332M |
| XFORX4 Pharmaceuticals, Inc. | Healthcare | Nov 5 | Sep '26 | $3.0M | +50.0% | −$20.0M | n/m | −$0.16 | n/m | -694.4% | — | $316M |
| ACBAurora Cannabis Inc. | Healthcare | Nov 5 | Sep '26 | $61.5M | −4.4% | — | n/m | $0.03 | n/m | -20.9% | −0.6 pp | $297M |
| INFUInfuSystems Holdings, Inc. | Healthcare | Nov 5 | Sep '26 | $38.0M | +5.6% | $3.0M | +50.0% | $0.15 | +36.4% | 12.6% | +2.2 pp | $296M |
| AGENAgenus Inc. | Healthcare | Nov 5 | Sep '26 | $31.0M | +3.3% | $3.0M | −95.3% | $0.02 | −99.0% | 36.2% | +51.3 pp | $281M |
| SABSSAB Biotherapeutics, Inc. | Healthcare | Nov 5 | Sep '26 | $0.0M | n/m | −$22.0M | −148.9% | −$0.24 | −141.4% | — | — | $266M |
| PROFProfound Medical Corp. | Healthcare | Nov 5 | Sep '26 | $10.0M | +100.0% | −$8.0M | n/m | −$0.21 | n/m | -79.6% | +89.0 pp | $259M |
| ALLOAllogene Therapeutics, Inc. | Healthcare | Nov 5 | Sep '26 | $0.0M | n/m | −$50.0M | n/m | −$0.15 | n/m | — | — | $258M |
| CAMPCAMP4 Therapeutics Corporation | Healthcare | Nov 5 | Sep '26pending | — | — | — | — | — | — | — | — | $251M |
| ARCTArcturus Therapeutics Holdings Inc. | Healthcare | Nov 5 | Sep '26 | $18.0M | +5.9% | −$7.0M | n/m | −$0.26 | n/m | -50.2% | +46.1 pp | $230M |
| KROSKeros Therapeutics, Inc. | Healthcare | Nov 5 | Sep '26 | $40.0M | +185.7% | $14.0M | n/m | $0.70 | n/m | 32.0% | +139.9 pp | $222M |
| CABACabaletta Bio, Inc. | Healthcare | Nov 5 | Sep '26 | $0.0M | n/m | −$53.0M | n/m | −$0.28 | n/m | — | — | $220M |
| QSIQuantum-Si Incorporated | Healthcare | Nov 5 | Sep '26 | $0.0M | −100.0% | −$22.0M | n/m | −$0.10 | n/m | — | — | $202M |
| TRDAEntrada Therapeutics, Inc. | Healthcare | Nov 5 | Sep '26 | $1.0M | −50.0% | −$40.0M | n/m | −$0.94 | n/m | — | — | $194M |
| BIOABioAge Labs, Inc. | Healthcare | Nov 5 | Sep '26 | $0.0M | n/m | −$34.0M | n/m | −$0.73 | n/m | — | — | $192M |
| RNACCartesian Therapeutics, Inc. | Healthcare | Nov 5 | Sep '26 | $0.0M | n/m | −$11.0M | n/m | −$0.38 | n/m | — | — | $187M |
| PYXSPyxis Oncology, Inc. | Healthcare | Nov 5 | Sep '26 | $0.0M | n/m | −$20.0M | n/m | −$0.24 | n/m | — | — | $172M |
| KRROKorro Bio, Inc. | Healthcare | Nov 5 | Sep '26 | $0.0M | −100.0% | −$18.0M | n/m | −$0.98 | n/m | — | — | $169M |
| KRSAKorsana Biosciences, Inc. | Healthcare | Nov 5 | Sep '26 | $0.0M | −100.0% | −$46.0M | n/m | −$343.24 | n/m | — | — | $152M |
| INGNInogen, Inc | Healthcare | Nov 5 | Sep '26 | $77.0M | −16.3% | −$16.0M | n/m | −$0.61 | n/m | -20.2% | −12.5 pp | $148M |
| DHDefinitive Healthcare Corp. | Healthcare | Nov 5 | Sep '26 | $55.0M | −8.3% | −$4.0M | n/m | −$0.04 | n/m | -9.1% | +5.4 pp | $140M |
| NTHINeOnc Technologies Holdings, Inc. | Healthcare | Nov 5 | Sep '26 | $0.0M | n/m | −$4.0M | n/m | −$0.28 | n/m | — | — | $125M |
| FATEFate Therapeutics, Inc. | Healthcare | Nov 5 | Sep '26 | $0.0M | n/m | −$31.0M | n/m | −$0.25 | n/m | — | — | $119M |
| AKBAAkebia Therapeutics, Inc. | Healthcare | Nov 5 | Sep '26 | $37.0M | −37.3% | −$14.0M | −1,500% | −$0.05 | n/m | -31.1% | −38.6 pp | $111M |
| APYXApyx Medical Corporation | Healthcare | Nov 5 | Sep '26 | $14.0M | +7.7% | −$2.0M | n/m | −$0.04 | n/m | -4.1% | +2.4 pp | $108M |
| ORGOOrganogenesis Holdings Inc. - Class A | Healthcare | Nov 5 | Sep '26 | $45.0M | −70.0% | −$30.0M | −236.4% | −$0.25 | −327.3% | -64.9% | −79.3 pp | $105M |
| HCATHealth Catalyst, Inc | Healthcare | Nov 5 | Sep '26 | $56.0M | −26.3% | $40.0M | n/m | $0.53 | n/m | -28.0% | −5.0 pp | $104M |
| CCLDCareCloud, Inc. | Healthcare | Nov 5 | Sep '26 | $34.0M | +9.7% | $5.0M | +66.7% | $0.10 | +150.0% | 19.4% | +9.1 pp | $96M |
| VYGRVoyager Therapeutics, Inc. | Healthcare | Nov 5 | Sep '26 | $4.0M | −69.2% | −$25.0M | n/m | −$0.40 | n/m | -658.3% | −429.3 pp | $95M |
| NYXHNyxoah SA | Healthcare | Nov 5 | Sep '26 | $10.4M | +350.0% | — | n/m | −$0.20 | n/m | -238.5% | — | $92M |
| JYNTThe Joint Corp. | Healthcare | Nov 5 | Sep '26 | $14.0M | +7.7% | $0.0M | −100.0% | −$0.01 | −116.7% | 9.8% | +8.6 pp | $91M |
| SKINSkinHealth Systems Inc. | Healthcare | Nov 5 | Sep '26 | $69.0M | −2.8% | −$1.0M | n/m | −$0.14 | n/m | 7.2% | +16.0 pp | $90M |
| BDSXBiodesix, Inc. | Healthcare | Nov 5 | Sep '26 | $24.0M | +9.1% | −$8.0M | n/m | −$0.75 | n/m | -25.4% | +6.9 pp | $72M |
| VTVTvTv Therapeutics Inc. | Healthcare | Nov 5 | Sep '26 | $0.0M | n/m | −$12.0M | n/m | −$0.94 | n/m | — | — | $68M |
| CGTXCognition Therapeutics, Inc. | Healthcare | Nov 5 | Sep '26 | $0.0M | n/m | −$4.0M | n/m | −$0.04 | n/m | — | — | $60M |
| COCHEnvoy Medical, Inc. | Healthcare | Nov 5 | Sep '26 | $0.0M | n/m | −$4.0M | n/m | −$0.50 | n/m | — | — | $53M |
| RNXTRenovoRx, Inc. | Healthcare | Nov 5 | Sep '26 | $1.0M | n/m | −$4.0M | n/m | −$0.08 | n/m | -303.6% | — | $50M |
| ALDXAldeyra Therapeutics, Inc. | Healthcare | Nov 5 | Sep '26 | $0.0M | n/m | −$4.0M | n/m | −$0.06 | n/m | — | — | $42M |
| DWTXDogwood Therapeutics, Inc. | Healthcare | Nov 5 | Sep '26 | $0.0M | n/m | −$5.0M | n/m | −$0.14 | n/m | — | — | $41M |
| ELUTElutia, Inc. | Healthcare | Nov 5 | Sep '26 | $1.0M | n/m | −$1.0M | n/m | −$0.03 | n/m | -606.5% | — | $38M |
| TENXTenax Therapeutics, Inc. | Healthcare | Nov 5 | Sep '26 | $0.0M | n/m | −$17.0M | n/m | −$0.31 | n/m | — | — | $38M |
| CRBUCaribou Biosciences, Inc. | Healthcare | Nov 5 | Sep '26 | $2.0M | 0.0% | −$27.0M | n/m | −$0.25 | n/m | — | — | $37M |
| NEPHNephros, Inc. | Healthcare | Nov 5 | Sep '26 | $6.0M | +20.0% | $1.0M | n/m | $0.05 | +66.7% | 8.9% | +2.3 pp | $32M |
| INMBINmune Bio Inc. | Healthcare | Nov 5 | Sep '26 | $0.0M | n/m | −$5.0M | n/m | −$0.17 | n/m | — | — | $30M |
| ELTXElicio Therapeutics, Inc. | Healthcare | Nov 5 | Sep '26 | $0.0M | n/m | −$8.0M | n/m | −$0.30 | n/m | — | — | $27M |
| ACETAdicet Bio, Inc. | Healthcare | Nov 5 | Sep '26 | $0.0M | n/m | −$19.0M | n/m | −$1.76 | n/m | — | — | $26M |
| FLNAFilana Therapeutics, Inc. | Healthcare | Nov 5 | Sep '26 | $0.0M | n/m | −$11.0M | n/m | −$0.22 | n/m | — | — | $23M |
| SCYXSCYNEXIS, Inc. | Healthcare | Nov 5 | Sep '26 | $0.0M | n/m | −$8.0M | n/m | −$0.71 | n/m | — | — | $18M |
| LPCNLipocine Inc. | Healthcare | Nov 5 | Sep '26 | $2.0M | n/m | −$1.0M | n/m | −$0.08 | n/m | -37.9% | — | $18M |
- Report dates come from the earnings calendar (dates loaded Oct 4 to Dec 9); figures come from the quarterly statements stored for each company. Click a ticker for its full statements.
- YoY compares the reported quarter with the same quarter a year earlier. n/m (not meaningful) means the year-earlier figure was zero or negative, so a percentage change would not describe it. Margin change is in percentage points.
- pending: the company has reported, but that quarter is not in our statements yet. Revenue marked † is the announced figure from the earnings calendar; the other columns fill in once the statements update.
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.